La evolucion /

Por Crusafont Pairó, Miguel, Melendez, B., Aguirre, E.
Publicado em 1966

P04.18 PROGNOSIS IMPACT OF THE REGIONAL DISTRIBUTION OF MGMT GENE METHYLATION ACCORDING TO THE CPGISLAND METHYLATOR PHENOTYPE AND AGE IN HIGH-GRADE GLIOMAS

Por Mur, P., de Lope, A. Rodriguez, Hernandez-Iglesias, T., Diaz, F., Ribalta, T., Fiaño, C., Garcia, J.F., Rey, J.A., Mollejo, M., Meléndez, B.
Publicado em 2014

P01.126 Frequent Tp53 and ATRX/DAXX gene alterations in giant cell IDH-Wildtype Glioblastomas

Por Cantero Montenegro, D, D’Haene, N, Rodríguez de Lope, Á, Sepulveda, J, de Neve, N, Fiaño, C, Gutiérrez-Guamán, M, Mollejo, M, Salmon, I, Hernandez-Laín, A, Melendez, B
Publicado no Neuro Oncol (2018)

Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action

Por Lorente, M, Torres, S, Salazar, M, Carracedo, A, Hernández-Tiedra, S, Rodríguez-Fornés, F, García-Taboada, E, Meléndez, B, Mollejo, M, Campos-Martín, Y, Lakatosh, S A, Barcia, J, Guzmán, M, Velasco, G
Publicado em 2011

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

Por Park, J, Talukder, AH, Lim, SA, Kim, K, Pan, K, Melendez, B, Bradley, SD, Jackson, KR, Khalili, JS, Wang, J, Creasy, C, Pan, BF, Woodman, SE, Bernatchez, C, Hawke, D, Hwu, P, Lee, KM, Roszik, J, Lizée, G, Yee, C
Publicado no Cancer Immunol Res (2017)